Evidence map›Paper›PMID 29460750›Full record

ArticleEmerging infectious diseases2018

Whole-Genome Analysis of Mycobacterium tuberculosis from Patients with Tuberculous Spondylitis, Russia.

Ekaterina Chernyaeva, Mikhail Rotkevich, Ksenia Krasheninnikova, Andrey Yurchenko, Anna Vyazovaya, Igor Mokrousov, Natalia Solovieva, Viacheslav Zhuravlev, Piotr Yablonsky, Stephen J O'Brien

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Whole genome sequencing of drug resistanceLife science alliance · 2023
    Article
  3. Article
  4. Population structure of Mycobacterium tuberculosis from referral clinics in Western Siberia, Russia: Before and during the Covid-19 pandemic.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2022
    Article
  5. Article
  6. Genomic Variations in Drug ResistantAntibiotics (Basel, Switzerland) · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ekaterina Chernyaeva
Mikhail Rotkevich
Ksenia Krasheninnikova
Andrey Yurchenko
Anna Vyazovaya
Igor Mokrousov
Natalia Solovieva
Viacheslav Zhuravlev
Piotr Yablonsky
Stephen J O'Brien

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whole-genome analysis of Mycobacterium tuberculosis isolates collected in Russia (N = 71) from patients with tuberculous spondylitis supports a detailed characterization of pathogen strain distributions and drug resistance phenotype, plus distinguished occurrence and association of known resistance mutations. We identify known and novel genome determinants related to bacterial virulence, pathogenicity, and drug resistance.

Indexed as

Genome, BacterialWhole Genome SequencingAntitubercular AgentsDrug Resistance, BacterialGeographyHumansMicrobial Sensitivity TestsMutationMycobacterium tuberculosisPhylogenyRussiaSpondylitisTuberculosisVirulenceAntitubercular Agentsantimicrobial resistancebacteriabacterial virulencedrug resistancegenetic markersgenome determinantsMycobacterium tuberculosispathogenicityphylogenyRussiatuberculosis and other mycobacteriatuberculous spondylitisWGSwhole-genome sequencing

Identifiers

PMID29460750
PMCPMC5823328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.